Literature DB >> 11506057

Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program.

S L Volpe1, H W Huang, K Larpadisorn, I I Lesser.   

Abstract

OBJECTIVE: To investigate the effect of chromium picolinate (CP) supplementation on body composition, resting metabolic rate (RMR), selected biochemical parameters and iron and zinc status in moderately obese women participating in a 12-week exercise program.
METHODS: Forty-four women, 27 to 51 years of age, were randomly assigned to two groups based on their body mass index. Subjects received either 400 microg/day of chromium as a CP supplement or a placebo in double-blind fashion and participated in a supervised weight-training and walking program two days per week for 12 weeks. Body composition and RMR were measured at baseline, 6 and 12 weeks. Selected biochemical parameters and iron and zinc status were measured at baseline and 12 weeks.
RESULTS: Body composition and RMR were not significantly changed by CP supplementation. No significant differences in fasting plasma glucose, serum insulin, plasma glucagon, serum C-peptide and serum lipid concentrations or in iron and zinc indices were found between the two groups over time. Serum total cholesterol concentration significantly decreased (p = 0.0016) over time for all subjects combined, probably as a result of the exercise training. Exercise training significantly reduced total iron binding capacity (TIBC) by 3% for all subjects combined (p = 0.001 1).
CONCLUSIONS: Twelve weeks of 400 microg/day of chromium as a CP supplement did not significantly affect body composition, RMR, plasma glucose, serum insulin, plasma glucagon, serum C-peptide and serum lipid concentrations or iron and zinc indices in moderately obese women placed on an exercise program. The changes in serum total cholesterol levels and TIBC were a result of the exercise program.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506057     DOI: 10.1080/07315724.2001.10719050

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  15 in total

Review 1.  Chromium Supplementation; Negotiation with Diabetes Mellitus, Hyperlipidemia and Depression.

Authors:  Amir Khodavirdipour; Fatemeh Haddadi; Shiva Keshavarzi
Journal:  J Diabetes Metab Disord       Date:  2020-03-05

Review 2.  ISSN exercise & sports nutrition review update: research & recommendations.

Authors:  Chad M Kerksick; Colin D Wilborn; Michael D Roberts; Abbie Smith-Ryan; Susan M Kleiner; Ralf Jäger; Rick Collins; Mathew Cooke; Jaci N Davis; Elfego Galvan; Mike Greenwood; Lonnie M Lowery; Robert Wildman; Jose Antonio; Richard B Kreider
Journal:  J Int Soc Sports Nutr       Date:  2018-08-01       Impact factor: 5.150

Review 3.  Supplements with purported effects on muscle mass and strength.

Authors:  Pedro L Valenzuela; Javier S Morales; Enzo Emanuele; Helios Pareja-Galeano; Alejandro Lucia
Journal:  Eur J Nutr       Date:  2019-01-02       Impact factor: 5.614

Review 4.  Chromium supplements for glycemic control in type 2 diabetes: limited evidence of effectiveness.

Authors:  Rebecca B Costello; Johanna T Dwyer; Regan L Bailey
Journal:  Nutr Rev       Date:  2016-05-31       Impact factor: 7.110

Review 5.  Nutritional deficiencies in morbidly obese patients: a new form of malnutrition? Part B: minerals.

Authors:  Orit Kaidar-Person; Benjamin Person; Samuel Szomstein; Raul J Rosenthal
Journal:  Obes Surg       Date:  2008-05-07       Impact factor: 4.129

6.  A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study.

Authors:  Kimberly A Brownley; Ann Von Holle; Robert M Hamer; Maria La Via; Cynthia M Bulik
Journal:  J Psychosom Res       Date:  2013-04-22       Impact factor: 3.006

7.  Risk of Type 2 Diabetes Is Lower in US Adults Taking Chromium-Containing Supplements.

Authors:  David J McIver; Ana Maria Grizales; John S Brownstein; Allison B Goldfine
Journal:  J Nutr       Date:  2015-10-07       Impact factor: 4.798

8.  Serum Chromium Levels in Type 2 Diabetic Patients and Its Association with Glycaemic Control.

Authors:  Kannan Rajendran; Senthil Manikandan; Lal Devayanivasudevan Nair; Rajendran Karuthodiyil; Nikhilan Vijayarajan; Rajiv Gnanasekar; Vivian V Kapil; Azeem S Mohamed
Journal:  J Clin Diagn Res       Date:  2015-11-01

Review 9.  The potential value and toxicity of chromium picolinate as a nutritional supplement, weight loss agent and muscle development agent.

Authors:  John B Vincent
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

10.  The way of serum chromium utilization may contribute to cardiovascular risk factors in centrally obese persons.

Authors:  Ewa Wysocka; Maciej Cymerys; Grzegorz Mielcarz; Wiesław Bryl; Sylwia Dzięgielewska; Lech Torliński
Journal:  Arch Med Sci       Date:  2011-05-17       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.